ENTITY

Argenx SE (ARGX US)

31
Analysis
Health Care • Netherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
Company Event • 22 Oct 2026 20:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 25 Feb 2027 19:00 • Upcoming
Add To Calendar

Q4 2026

Company Event • 14 Sep 2026 21:15 • Latest

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 08 Sep 2026 21:30

Wells Fargo 21st Annual Healthcare Conference

Company Event • 17 Aug 2026 20:30

Study update

x